| Literature DB >> 29988920 |
Hassan Hashemi1, Mehdi Khabazkhoob2,3, Mohammad Saatchi3, Hadi Ostadimoghaddam4, Abbasali Yekta5.
Abstract
PURPOSE: To determine the prevalence of visual impairment and blindness and related factors in the 1- to 90-year-old urban population of Mashhad.Entities:
Keywords: Blindness; Cross-sectional study; Low-vision; Middle-East; Visual impairment
Year: 2017 PMID: 29988920 PMCID: PMC6033729 DOI: 10.1016/j.joco.2017.01.003
Source DB: PubMed Journal: J Curr Ophthalmol ISSN: 2452-2325
The age and sex distribution of the population of Mashhad and participants in the study.
| Age | The entire population of Mashhad in 2006 | Participants in this study | ||||||
|---|---|---|---|---|---|---|---|---|
| Male | Female | Total | % of total | Male | Female | Total | % of total | |
| 0–9 | 200,954 | 192,718 | 393,672 | 16.1 | 183 | 204 | 387 | 12.4 |
| 10–19 | 258,510 | 253,701 | 512,211 | 20.9 | 260 | 358 | 618 | 19.7 |
| 20–29 | 284,633 | 293,626 | 578,259 | 23.6 | 119 | 383 | 502 | 16.0 |
| 30–39 | 185,683 | 181,111 | 366,794 | 15.0 | 119 | 348 | 467 | 14.9 |
| 40–49 | 141,705 | 137,374 | 279,079 | 11.4 | 169 | 321 | 490 | 15.6 |
| 50–59 | 81,898 | 79,164 | 161,062 | 6.6 | 175 | 182 | 357 | 11.4 |
| 60–69 | 46,241 | 42,749 | 88,990 | 3.6 | 70 | 54 | 124 | 4.0 |
| 70–79 | 26,690 | 25,455 | 52,145 | 2.1 | 65 | 54 | 119 | 3.8 |
| 80–89 | 8954 | 8534 | 17,488 | 0.7 | 29 | 34 | 63 | 2.0 |
| Above 90 | 902 | 1110 | 2012 | 0.1 | 2 | 3 | 5 | 0.2 |
| Total | 1,236,170 | 1,215,542 | 2,451,712 | 100.0 | 1191 | 1941 | 3132 | 100.0 |
The prevalence of visual impairment, low vision, and blindness in this study.
| n | Based on best corrected visual acuity | Based on presenting visual acuity | |||||
|---|---|---|---|---|---|---|---|
| Visual impairment | Low vision | Blindness | Visual impairment | Low vision | Blindness | ||
| % (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | ||
| Total | 2785 | 2.23 (1.54–2.91) | 1.90 (1.3–2.51) | 0.32 (0.1–0.55) | 3.95 (3.13–4.77) | 3.09 (2.37–3.8) | 0.86 (0.51–1.22) |
| Age-sex standardized prevalence | 2.76 (1.9–3.63) | 2.42 (1.61–3.22) | 0.35 (0.09–0.61) | 4.31 (3.35–5.27) | 3.46 (2.58–4.33) | 0.85 (0.48–1.23) | |
| Male | 964 | 2.39 (1.24–3.53) | 1.97 (0.92–3.02) | 0.41 (0.01–0.82) | 3.84 (2.42–5.26) | 2.90 (1.68–4.13) | 0.93 (0.27–1.6) |
| Female | 1821 | 2.14 (1.44–2.85) | 1.87 (1.23–2.5) | 0.27 (0.04–0.51) | 4.01 (3.08–4.93) | 3.19 (2.37–4) | 0.82 (0.42–1.22) |
| Age group (years) | |||||||
| 1–5 | 126 | 1.59 (0.41–6.19) | 1.59 (0.41–6.19) | 0 | 1.59 (0.41–6.19) | 1.59 (0.41–6.19) | 00 |
| 5–15 | 640 | 0.31 (0.08–1.19) | 0.31 (0.08–1.19) | 0 | 1.25 (0.43–2.08) | 0.31 (0.08–1.19) | 0.94 (0.2–1.68) |
| 16–25 | 504 | 0.4 (0.1–1.59) | 0.4 (0.1–1.59) | 0 | 1.39 (0.36–2.42) | 0.8 (0.02–1.57) | 0.60 (0.19–1.86) |
| 26–35 | 473 | 1.9 (0.66–3.15) | 1.48 (0.38–2.58) | 0.42 (0.11–1.69) | 4.02 (2.26–5.77) | 3.59 (1.93–5.26) | 0.42 (0.11–1.69) |
| 36–45 | 488 | 0.61 (0.15–2.52) | 0.61 (0.15–2.52) | 0 | 1.64 (0.44–2.84) | 1.64 (0.44–2.84) | 0 |
| 46–55 | 350 | 0.29 (0.04–2.04) | 0.29 (0.04–2.04) | 0 | 2 (0.51–3.49) | 2 (0.51–3.49) | 0 |
| 55–65 | 126 | 7.94 (2.54–13.33) | 4.76 (0.46–9.06) | 3.17 (1.01–9.99) | 19.84 (11.76–27.92) | 14.29 (7.69–20.89) | 5.56 (0.69–10.42) |
| >65 | 78 | 42.31 (31.13–53.49) | 38.46 (27.19–49.74) | 3.85 (1.26–11.76) | 43.59 (32.37–54.81) | 35.9 (24.28–47.52) | 7.69 (2.04–13.35) |
CI: Confidence interval.
The 95% CI was calculated by binomial distribution.
Causes of visual impairment in the participants based on presenting and best corrected vision.
| Presenting visual acuity | Best corrected visual acuity | |||
|---|---|---|---|---|
| Frequency | Percent | Frequency | Percent | |
| Uncorrected refractive error | 46 | 41.8 | 0 | 0 |
| Cataract | 22 | 20.0 | 21 | 33.87 |
| Amblyopia | 5 | 4.5 | 5 | 8.06 |
| Diabet retinopaty | 4 | 3.6 | 3 | 4.84 |
| Retinitis pigmentosa | 3 | 2.7 | 3 | 4.84 |
| Keratoconus | 5 | 4.5 | 4 | 6.45 |
| Corneal opacity | 4 | 3.6 | 4 | 6.45 |
| Chorioretinal atrophy | 2 | 1.8 | 2 | 3.23 |
| Optic atrophy | 1 | 0.9 | 1 | 1.61 |
| Glaucoma | 8 | 7.3 | 5 | 8.06 |
| Age related maculapathy | 10 | 9.1 | 7 | 11.29 |
| Unknown | 0 | 0 | 7 | 11.29 |
The association between visual impairment based on presenting visual acuity and best corrected visual acuity and their risk factors in multiple regression logistic.
| Variable | Presenting visual acuity | Best corrected visual acuity | |||
|---|---|---|---|---|---|
| Odds ratio (95% CI) | Odds ratio | ||||
| Gender | Female | 1.00 | 1.00 | ||
| Male | 0.74 (0.46–1.18) | 0.203 | 0.63 (0.34–1.15) | 0.133 | |
| Age | Year | 1.06 (1.04–1.07) | <0.001 | 1.09 (1.07–1.12) | <0.001 |
| Education | Illiterate | 1.00 | 1.00 | ||
| Without higher education (1–14 years) | 0.31 (0.18–0.52) | <0.001 | 0.30 (0.15–0.6) | <0.001 | |
| Higher education (>14 years) | 0.16 (0.06–0.38) | <0.001 | 0.27 (0.09–0.83) | 0.022 | |
| Income | 1.36 (1.21–1.72) | <0.001 | 1.72 (1.41–2.05) | <0.001 | |
CI: Confidence interval.
Comparison of the results of blindness and leading causes of visual impairment in worldwide.
| WHO region | Study | Age (years) | Leading causes of visual impairment | Prevalence of blindness | |
|---|---|---|---|---|---|
| By presenting visual acuity | By corrected visual acuity | ||||
| Southeast Asia | India – Delhi | >40 | Refractive errors | 1.2 | |
| South Korea – Seoul | >40 | Refractive errors | Cataracts | 0.26 | |
| The Americas | El Salvador | >50 | Cataracts | 2.4 | |
| Brazil – Botafogo | 1–91 | Refractive errors | Cataracts | 2.2 | |
| United States – Los Angeles | >40 | Cataract | 0.4 | ||
| Paraguay | >50 | Refractive errors | Cataracts | 1 | |
| Western Pacific | Japan | >40 | Glaucoma | not reported | |
| Singapore | 40–80 | Refractive errors | Cataracts | 0.67 | |
| Africa | Ghana | >40 | Cataracts | 0.75 | |
| South Africa | 1–92 | Refractive errors | Cataracts | 10.90 | |
| Nigeria | >40 | Cataracts | 4.20 | ||
| Libya | >50 | Cataracts | 3.25 | ||
| Europe | United Kingdom | 42–90 | Refractive errors | 0.74 | |
| Germany | >1 | AMD | 0.04 | ||
| Denmark | 20–84 | Myopia-related retinal disorders | 0.20 | ||
| Eastern Mediterranean | Jordan | >40 | Cataract | ||
| Saudi Arabia | >18 | Refractive errors | not reported | ||
| Egypt | >40 | Refractive errors | 9.30 | ||
| Iran – Sari | >54 | Refractive errors | Cataract | 3.70 | |